000 01144 a2200337 4500
005 20250513051131.0
264 0 _c19940103
008 199401s 0 0 eng d
022 _a0160-9289
024 7 _a10.1002/clc.4960160910
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoden, D M
245 0 0 _aTorsade de pointes.
_h[electronic resource]
260 _bClinical cardiology
_cSep 1993
300 _a683-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aAnti-Arrhythmia Agents
_xadverse effects
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aDogs
650 0 4 _aElectrocardiography
650 0 4 _aErythromycin
_xadverse effects
650 0 4 _aHeart Rate
650 0 4 _aHistamine Antagonists
_xadverse effects
650 0 4 _aHumans
650 0 4 _aLong QT Syndrome
_xcomplications
650 0 4 _aTorsades de Pointes
_xdrug therapy
773 0 _tClinical cardiology
_gvol. 16
_gno. 9
_gp. 683-6
856 4 0 _uhttps://doi.org/10.1002/clc.4960160910
_zAvailable from publisher's website
999 _c7901557
_d7901557